Description
The INDICAID™ COVID-19 Rapid Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARSCoV-2 indirect anterior nasal swab specimens from individuals who are suspected of COVID-19 by their health care provider within the first five (5) days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect CO VID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
